Call us at (866) 287-2425 for assistance.
CoviDx™ SARS CoV-2 Rapid Antigen Test
Spectrum Medical Diagnostics is pleased to launch the latest rapid COVID-19 antigen screening device designed to detect the new known variants!
This product is made in North America and offers superior clinical accuracy & sensitivity.
Enhance your COVID-19 screening protocol with this new, highly sensitive test to guarantee the safety of your workplace and employees.
Key Product Features
- Specimen type: Nasal or Nasopharyngeal.
- Results: 15-20 minutes.
- Pre-filled buffer vials.
- Made in North America.
- Simple test procedure.
- Simple results interpretation.
Interested in learning more about the product?
Contact us here with any questions you may have!
- Diagnoses at the point of care.
- Performance demonstrated 100% PPA and 95% NPA in patientswith Ct values < 352.
- Clinical performance compared against high sensitivity PCR gold standard3.
- High specificity despite times of low prevalence during enrollment.
- Pre-filled extraction vials standardize workflow and enable greater test distribution via multiple independent workstations.
- Testing should follow provincial or territorial guidance and be administered regularly to employees in accordance with the interim guidance on the use of rapid antigen detection tests for identifying SARS-CoV-2 infection.
- Refer to package insert for full performance and best product experience.
- PCR is the gold standard for diagnosing COVID-19.